Less patients with disease activity1

Less patients with disease activity¹

• Assessing disease activity: The clinical measure of functional and anatomical outcomes in wet AMD in HAWK and HARRIER¹

AMD=age-related macular degeneration

*Secondary endpoint in HAWK and HARRIER, confirmatory analysis in HAWK only (1-sided P values for superiority of Beovu).^2,3

REFERENCES

1. Summary of Product Characteristics. Novartis; 2020.

2. Data on file. RTH258-C001. Novartis; 2019.

3. Data on file. RTH258-C002. Novartis; 2019

Beovu^® SmPC